Recruiting
Idiopathic pulmonary fibrosis
RecruitingInvestigational
A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
Investigational
- Disease:Idiopathic pulmonary fibrosis
- Substances:HUMANISED IGG1 LALAPS-YTE MONOCLONAL ANTIBODY AGAINST LYSOPHOSPHATIDIC ACID RECEPTOR 1
Countries:
Greece
Greece- Participants:18–64 years · 65+ years
- Substances:HUMANISED IGG1 LALAPS-YTE MONOCLONAL ANTIBODY AGAINST LYSOPHOSPHATIDIC ACID RECEPTOR 1
